Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference
February 22 2019 - 8:01AM
Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage
biopharmaceutical company developing novel cell and gene therapies
for serious diseases, today announced that João Siffert, M.D.,
Chief Executive Officer, will participate in a fireside chat at the
8th Annual SVB Leerink Global Healthcare Conference in New York
City on Wednesday, February 27, 2019 at 1:00 p.m. ET.
A live webcast of the fireside chat will be
available on the investor section of the Abeona Therapeutics
website, www.abeonatherapeutics.com, and an archived replay will be
accessible for up to 30 days.
About Abeona Therapeutics Abeona Therapeutics
Inc. is a clinical-stage biopharmaceutical company developing cell
and gene therapies for life-threatening rare genetic diseases.
Abeona's lead programs include EB-101, its gene-corrected cell
therapy for recessive dystrophic epidermolysis bullosa, and
ABO-102, a novel AAV9 based gene therapy for Sanfilippo syndrome
type A (MPS IIIA). The Company’s portfolio of AAV9 based gene
therapies also features ABO-101 for Sanfilippo syndrome type B (MPS
IIIB), and ABO-201 and ABO-202 for CLN3 disease and CLN1 disease,
respectively. Its preclinical assets include ABO-401, which uses
the novel AIM™ AAV vector platform to address all mutations of
cystic fibrosis. Abeona has received numerous regulatory
designations from the FDA and EMA for its pipeline candidates and
is the only company with Regenerative Medicine Advanced Therapy
designation for two investigational therapies (EB-101 and ABO-102).
For more information, visit www.abeonatherapeutics.com.
Investor Contact:Sofia WarnerDirector, Investor
RelationsAbeona Therapeutics Inc.+1 (646)
813-4710swarner@abeonatherapeutics.com
Media Contact:Scott SantiamoDirector, Corporate
CommunicationsAbeona Therapeutics Inc.+1 (718)
344-5843ssantiamo@abeonatherapeutics.com
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Abeona Therapeutics (NASDAQ:ABEO)
Historical Stock Chart
From Sep 2023 to Sep 2024